These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 8101380)

  • 21. A neurotoxic regimen of MDMA suppresses behavioral, thermal and neurochemical responses to subsequent MDMA administration.
    Shankaran M; Gudelsky GA
    Psychopharmacology (Berl); 1999 Nov; 147(1):66-72. PubMed ID: 10591870
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ketanserin pretreatment attenuates MDMA-induced dopamine release in the striatum as measured by in vivo microdialysis.
    Nash JF
    Life Sci; 1990; 47(26):2401-8. PubMed ID: 1979830
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies on the role of dopamine in the degeneration of 5-HT nerve endings in the brain of Dark Agouti rats following 3,4-methylenedioxymethamphetamine (MDMA or 'ecstasy') administration.
    Colado MI; O'Shea E; Granados R; Esteban B; Martín AB; Green AR
    Br J Pharmacol; 1999 Feb; 126(4):911-24. PubMed ID: 10193771
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence for a role of energy dysregulation in the MDMA-induced depletion of brain 5-HT.
    Darvesh AS; Gudelsky GA
    Brain Res; 2005 Sep; 1056(2):168-75. PubMed ID: 16098955
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serotonin neurotoxicity in rats after combined treatment with a dopaminergic agent followed by a nonneurotoxic 3,4-methylenedioxymethamphetamine (MDMA) analogue.
    Johnson MP; Huang XM; Nichols DE
    Pharmacol Biochem Behav; 1991 Dec; 40(4):915-22. PubMed ID: 1726189
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhancement of 3,4-methylenedioxymethamphetamine neurotoxicity by the energy inhibitor malonate.
    Nixdorf WL; Burrows KB; Gudelsky GA; Yamamoto BK
    J Neurochem; 2001 Apr; 77(2):647-54. PubMed ID: 11299327
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the neurotoxicity of N-methyl-1-(4-methoxyphenyl)-2-aminopropane (para-methoxymethamphetamine, PMMA).
    Steele TD; Katz JL; Ricaurte GA
    Brain Res; 1992 Sep; 589(2):349-52. PubMed ID: 1382813
    [TBL] [Abstract][Full Text] [Related]  

  • 28. (+/-)3,4-Methylenedioxymethamphetamine (MDMA) produces long-term reductions in brain 5-hydroxytryptamine in rats.
    Mokler DJ; Robinson SE; Rosecrans JA
    Eur J Pharmacol; 1987 Jun; 138(2):265-8. PubMed ID: 2887440
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 3,4-Methylenedioxymethamphetamine induces monoamine release, but not toxicity, when administered centrally at a concentration occurring following a peripherally injected neurotoxic dose.
    Esteban B; O'Shea E; Camarero J; Sanchez V; Green AR; Colado MI
    Psychopharmacology (Berl); 2001 Mar; 154(3):251-60. PubMed ID: 11351932
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence for the involvement of nitric oxide in 3,4-methylenedioxymethamphetamine-induced serotonin depletion in the rat brain.
    Darvesh AS; Yamamoto BK; Gudelsky GA
    J Pharmacol Exp Ther; 2005 Feb; 312(2):694-701. PubMed ID: 15456837
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of benzylpiperazine derivatives on the neurotoxicity of 3,4-methylenedioxymethamphetamine in rat brain.
    Hashimoto K; Maeda H; Goromaru T
    Brain Res; 1992 Sep; 590(1-2):341-4. PubMed ID: 1384935
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differences between rats and mice in MDMA (methylenedioxymethylamphetamine) neurotoxicity.
    Logan BJ; Laverty R; Sanderson WD; Yee YB
    Eur J Pharmacol; 1988 Aug; 152(3):227-34. PubMed ID: 2906000
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The acute effect in rats of 3,4-methylenedioxyethamphetamine (MDEA, "eve") on body temperature and long term degeneration of 5-HT neurones in brain: a comparison with MDMA ("ecstasy").
    Colado MI; Granados R; O'Shea E; Esteban B; Green AR
    Pharmacol Toxicol; 1999 Jun; 84(6):261-6. PubMed ID: 10401727
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of acute brain tyrosine depletion on MDMA-induced changes in brain 5-HT.
    Rodsiri R; Green AR; Marsden CA; Fone KC
    J Psychopharmacol; 2010 Feb; 24(2):267-74. PubMed ID: 19965941
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Locomotor stimulation produced by 3,4-methylenedioxymethamphetamine (MDMA) is correlated with dialysate levels of serotonin and dopamine in rat brain.
    Baumann MH; Clark RD; Rothman RB
    Pharmacol Biochem Behav; 2008 Aug; 90(2):208-17. PubMed ID: 18403002
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of GBR 12909 and fluoxetine on the acute and long term changes induced by MDMA ('ecstasy') on the 5-HT and dopamine concentrations in mouse brain.
    O'Shea E; Esteban B; Camarero J; Green AR; Colado MI
    Neuropharmacology; 2001; 40(1):65-74. PubMed ID: 11077072
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of salicylate on 3,4-methylenedioxymethamphetamine (MDMA)-induced neurotoxicity in rats.
    Yeh SY
    Pharmacol Biochem Behav; 1997 Nov; 58(3):701-8. PubMed ID: 9329062
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serotonin1B receptor activation mimics behavioral effects of presynaptic serotonin release.
    Rempel NL; Callaway CW; Geyer MA
    Neuropsychopharmacology; 1993 May; 8(3):201-11. PubMed ID: 8099482
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lack of serotonin neurotoxicity after intraraphe microinjection of (+)-3,4-methylenedioxymethamphetamine (MDMA).
    Paris JM; Cunningham KA
    Brain Res Bull; 1992 Jan; 28(1):115-9. PubMed ID: 1347247
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of 3,4-methylenedioxymethamphetamine on [3H]paroxetine binding in the frontal cortex and blood platelets of rats.
    Nash JF; Arora RC; Schreiber MA; Meltzer HY
    Biochem Pharmacol; 1991 Jan; 41(1):79-84. PubMed ID: 1702633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.